Yang Xue

411 total citations
21 papers, 265 citations indexed

About

Yang Xue is a scholar working on Molecular Biology, Cancer Research and Epidemiology. According to data from OpenAlex, Yang Xue has authored 21 papers receiving a total of 265 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 5 papers in Cancer Research and 4 papers in Epidemiology. Recurrent topics in Yang Xue's work include Cancer-related molecular mechanisms research (4 papers), Long-Term Effects of COVID-19 (3 papers) and MicroRNA in disease regulation (3 papers). Yang Xue is often cited by papers focused on Cancer-related molecular mechanisms research (4 papers), Long-Term Effects of COVID-19 (3 papers) and MicroRNA in disease regulation (3 papers). Yang Xue collaborates with scholars based in China, United States and Sweden. Yang Xue's co-authors include Shao Liu, Mei Peng, Jia He, Ying Xue, Zhicheng Gong, Di Zhong, Guozhong Li, Yanmin Zhou, Xiangzhen Shen and Chao Wen and has published in prestigious journals such as Scientific Reports, Clinical Cancer Research and Neuroscience.

In The Last Decade

Yang Xue

19 papers receiving 262 citations

Peers

Yang Xue
Kuoyuan Cheng United States
Alexandria Lau Hong Kong
Yinyin Xu China
Lidan Hu China
Kuoyuan Cheng United States
Yang Xue
Citations per year, relative to Yang Xue Yang Xue (= 1×) peers Kuoyuan Cheng

Countries citing papers authored by Yang Xue

Since Specialization
Citations

This map shows the geographic impact of Yang Xue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yang Xue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yang Xue more than expected).

Fields of papers citing papers by Yang Xue

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yang Xue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yang Xue. The network helps show where Yang Xue may publish in the future.

Co-authorship network of co-authors of Yang Xue

This figure shows the co-authorship network connecting the top 25 collaborators of Yang Xue. A scholar is included among the top collaborators of Yang Xue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yang Xue. Yang Xue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xue, Yang, et al.. (2024). Novel peripheral blood mononuclear cell mRNA signature for IFN-beta therapy responsiveness prediction in multiple sclerosis. Autoimmunity. 57(1). 2332340–2332340. 1 indexed citations
3.
4.
Cao, Lihua, Xingyuan Jia, Hong-Juan He, et al.. (2022). Using a System Pharmacology Method to Search for the Potential Targets and Pathways of Yinqiaosan against COVID-19. Journal of Healthcare Engineering. 2022. 1–14. 3 indexed citations
8.
Chen, Hongping, Xuehui Fan, Xu Chen, et al.. (2021). Identification and Clinical Validation of Key Extracellular Proteins as the Potential Biomarkers in Relapsing-Remitting Multiple Sclerosis. Frontiers in Immunology. 12. 753929–753929. 21 indexed citations
10.
Hao, Erwei, Yanling Gong, Zhengcai Du, et al.. (2021). Analysis on application law of dampness-removing traditional Chinese medicines in treatment of coronavirus disease 2019. Chinese Herbal Medicines. 13(4). 518–524. 13 indexed citations
11.
Ouyang, Yan, Yang Xue, Shichao Zhang, et al.. (2021). Alternative splicing acts as an independent prognosticator in ovarian carcinoma. Scientific Reports. 11(1). 10413–10413. 15 indexed citations
12.
Zhang, Jinpeng, Ye Wang, Yang Xue, et al.. (2021). lncRNA MIR600HG Knockdown Alleviates Cognitive Impairment in Alzheimer’s Disease Through NEDD4L Mediated PINK1 Degradation. Journal of Alzheimer s Disease. 85(4). 1783–1794. 10 indexed citations
13.
Wang, Peng, et al.. (2021). [The role of respiratory therapists in the treatment of coronavirus disease 2019 patients in China].. PubMed. 33(6). 744–747. 2 indexed citations
14.
Peng, Mei, Jia He, Ying Xue, et al.. (2021). Role of Hypertension on the Severity of COVID-19: A Review. Journal of Cardiovascular Pharmacology. 78(5). e648–e655. 67 indexed citations
15.
Li, Xu, Yang Xue, Yanli Wen, et al.. (2020). SARS-CoV-2 RNA reference materials. Chinese Science Bulletin (Chinese Version). 65(22). 2363–2370. 2 indexed citations
16.
Xue, Yang, et al.. (2020). Effects of ACEI and ARB on COVID-19 patients: A meta-analysis. Journal of the Renin-Angiotensin-Aldosterone System. 21(4). 2691705161–2691705161. 15 indexed citations
17.
Li, Jiuyi, Yang Xue, Anna Wenger, et al.. (2019). Individual Assignment of Adult Diffuse Gliomas into the EM/PM Molecular Subtypes Using a TaqMan Low-Density Array. Clinical Cancer Research. 25(23). 7068–7077. 8 indexed citations
19.
Xue, Yang, et al.. (2016). Increased fatty acid β‐oxidation as a possible mechanism for fat‐reducing effect of betaine in broilers. Animal Science Journal. 87(8). 1005–1010. 31 indexed citations
20.
Zhang, Wanyu, Yang Xue, Chenxing Wu, et al.. (2016). Co-expression modules of NF1, PTEN and sprouty enable distinction of adult diffuse gliomas according to pathway activities of receptor tyrosine kinases. Oncotarget. 7(37). 59098–59114. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026